Recent Posts in side effects Category
Posted on Nov 8, 2011 By Jennifer Williams
A new study published November 6, 2011 in the Canadian Medical Association Jounral links oral contraceptives containing drospirenone (Yaz, Yasmin, Ocella, Beyaz) with a higher risk of venous ...
Continue reading "New Study of Irsaeli Women Reveals Increased Risk of DVT and Pulmonary Embolism in Yaz/Yasmin Users" »
Posted on Oct 27, 2011 By Jennifer Williams
The FDA released the report today from its study of the relative risks of various combined hormonal contraceptives (CHCs). The study compared recently marketed CHCs including Yasmin/Yaz, Ortho Evra ...
Continue reading "Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz" »
Posted on Oct 26, 2011 By Allen Law Firm
A new study published in the British Medical Journal today confirms previous studies that concluded users of Yaz and Yasmin are at least at twice the risk of venous thromboembolism compared with users ...
Continue reading "New Danish Study Confirms Increased Risk of Venous Thromboembolism in Yaz / Yasmin Users" »
Posted on Sep 27, 2011 By Jennifer Williams
On September 26, 2011 the FDA issued a Drug Safety Communication regarding its safety review of drospirenone-containing oral contraceptives such as Yasmin and Yaz. The FDA bulletin states that while ...
Continue reading "FDA to Convene Panel to Weigh Risks of Yasmin and Yaz" »
Posted on Jun 1, 2011 By Jackson Allen Williams, LLP
On May 31, 2011 the FDA issued a safety alert warning of a possible increased risk of blood clots associated with birth control pills containing drospirenone. Drospirenone is a hormone found in the ...
Continue reading "FDA Warns of Increased Risk of Blood Clots with Yaz and Yasmin" »
Posted on Apr 25, 2011 By Jackson Allen Williams, LLP
April 25, 2011 - Two articles published in British Medical Journal over the weekend confirm previous studies that show an increased risk of venous thromboembolic events including stroke , pulmonary ...
Continue reading "Two New Articles Confirm Increased Risk of Venous Thromboembolism in Yaz & Yasmin Users" »
Posted on Apr 19, 2011 By Jackson Allen Williams, LLP
On April 18, 2011 the Canadian Medical Association Journal published an article that reports a statistically significant increase in the risk of gallbladder diseases associated with dropserinone, ...
Continue reading "Yaz/Yasmin May Put Women at Increased Risk for Gallbladder Disease" »
Posted on Dec 6, 2010 By Allen Law Firm
As previously reported, the first "bellwether" case in the Yaz / Yasmin Multi-District Litigation will involve a woman who suffered a pulmonary embolism . Because so many of the women who have sued ...
Continue reading "First Yaz Case Will Involve Pulmonary Embolism" »
Posted on Aug 3, 2010 By Jennifer Williams
A study published in the Annals of Internal Medicine on Monday found that clinical trials for drugs are more likely to show positive results when they are funded by the pharmaceutical industry. ...
Continue reading "New Report Shows Industry Funded Studies More Likely to Have Positive Outcome" »
Posted on Jul 29, 2010 By Jennifer Williams
In the last two months alone, over 700 Yasmin / Yaz lawsuits have been filed in the federal multidistrict Yaz litigation. That brings the total number of Yasmin / Yaz lawsuits filed in federal court ...
Continue reading "Number of Yaz, Yasmin, Ocella, Gianvi Lawsuits Continues to Grow" »